# Tg Therapeutics (TGTX) — Analyst Forecast

TGTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tgtx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 0 | 1 | 8 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $72.00 | $78.67 | $86.00 | 3 |

Last price $56.00 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 1, 2026 | HC Wainwright & Co. | Maintained | Buy | $78.00 |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | $72.00 |
| Jul 27, 2026 | B. Riley Securities | Maintained | Buy | $86.00 |
| Jul 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $77.00 |
| Jul 7, 2026 | B of A Securities | Maintained | Underperform | $20.00 |
| Jul 6, 2026 | HC Wainwright & Co. | Maintained | Buy | $70.00 |
| May 27, 2026 | HC Wainwright & Co. | Maintained | Buy | $70.00 |
| May 6, 2026 | HC Wainwright & Co. | Maintained | Buy | $70.00 |
| Feb 2, 2026 | JP Morgan | Maintained | Overweight | $46.00 |
| Jan 15, 2026 | Goldman Sachs | Maintained | Neutral | $39.00 |
| Nov 3, 2025 | JP Morgan | Maintained | Overweight | $49.00 |
| Oct 6, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $60.00 |
| Sep 17, 2025 | B. Riley Securities | Maintained | Buy | $55.00 |
| Mar 4, 2025 | HC Wainwright & Co. | Maintained | Buy | $55.00 |
| Jan 15, 2025 | HC Wainwright & Co. | Maintained | Buy | $55.00 |
| Nov 25, 2024 | JP Morgan | Maintained | Overweight | $43.00 |
| Nov 5, 2024 | Goldman Sachs | Maintained | Neutral | $22.00 |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | $55.00 |
| Oct 29, 2024 | TD Cowen | Initiated Coverage | Buy | $50.00 |
| Sep 18, 2024 | HC Wainwright & Co. | Maintained | Buy | $49.00 |

## Frequently Asked Questions

### What is the price target for TGTX stock?

The average 12-month analyst price target for Tg Therapeutics (TGTX) is $78.67, with a high estimate of $86.00 and a low of $72.00, across 3 analysts.

### Is TGTX a buy, sell, or hold?

Analysts covering Tg Therapeutics currently average a Buy rating: 7 buy, 0 hold and 1 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for TGTX?

The average price target of $78.67 implies 40.48% upside from the last price of $56.00.

### What is the latest analyst rating on TGTX?

On Sep 1, 2026, HC Wainwright & Co. maintained Tg Therapeutics at Buy with a price target of $78.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).